GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » JHS Svendgaard Laboratories Ltd (BOM:532771) » Definitions » Cash, Cash Equivalents, Marketable Securities

JHS Svendgaard Laboratories (BOM:532771) Cash, Cash Equivalents, Marketable Securities : ₹114.3 Mil (As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is JHS Svendgaard Laboratories Cash, Cash Equivalents, Marketable Securities?

JHS Svendgaard Laboratories's quarterly cash, cash equivalents, marketable securities declined from Sep. 2023 (₹341.68 Mil) to Dec. 2023 (₹0.00 Mil) but then increased from Dec. 2023 (₹0.00 Mil) to Mar. 2024 (₹114.30 Mil).

JHS Svendgaard Laboratories's annual cash, cash equivalents, marketable securities increased from Mar. 2022 (₹80.19 Mil) to Mar. 2023 (₹399.30 Mil) but then declined from Mar. 2023 (₹399.30 Mil) to Mar. 2024 (₹114.30 Mil).


JHS Svendgaard Laboratories Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for JHS Svendgaard Laboratories's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JHS Svendgaard Laboratories Cash, Cash Equivalents, Marketable Securities Chart

JHS Svendgaard Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.52 230.38 80.19 399.30 114.30

JHS Svendgaard Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 399.30 - 341.68 - 114.30

JHS Svendgaard Laboratories Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


JHS Svendgaard Laboratories  (BOM:532771) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


JHS Svendgaard Laboratories Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of JHS Svendgaard Laboratories's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


JHS Svendgaard Laboratories (BOM:532771) Business Description

Traded in Other Exchanges
Address
Mathura Road, B-1/E-23, Mohan Co-operative Industrial Area, New Delhi, IND, 110044
JHS Svendgaard Laboratories Ltd is a manufacturer of dental and oral care products. Its business segments include Manufacturing Business; Other than Manufacturing Business and Retail Business. Its product portfolio includes a toothbrush, toothpaste, mouthwash, laundry detergent, hand sanitizer, and room fresheners. It sells products under its own brand name and private labels including Dr. Gold, P&G, Amway, Future Group, Dabur, Elder Pharma, J. L. Morison's among others, and in the international market are - Dr. Fresh, Boots, Peanuts, and Lavoris. It generates the majority of the revenue from the Manufacturing Business segment.

JHS Svendgaard Laboratories (BOM:532771) Headlines

No Headlines